首  页 调研公司 培训会议 行业情报 付费报告 免费报告 调研文库 求职招聘 执行峰会 邮箱/论坛
                                          我的帐户  会员登陆  会员注册
热点话题 | 行业动态 | 项目招标 | 咨询黄页 | 涉外调查                                   注册成会员                  
定性研究 | 服务评估 | 定性研究 | 消费者研究 | 产品开发 | 品牌传播
汽车 | 通信 | 经济 | 房地产 | 互联网                                  我的帐户 会员登陆 会员注册
IT、液晶 | 电信增值 | 网络无线 | 饮食烟酒 | 家电、3C | 电子电工 | 2008报告预订(|) | 我的帐户 | 购买帮助 | 购物车 | 忘记密码              
IT、液晶 | 电信增值 | 网络无线 | 饮食烟酒 | 家电、3C | 电子电工
求职招聘区 | 委托代理区 | 行业讨论区 | 调研学习区 | 系统服务区
行业分类
付费报告检索: 
3see首页 > 英文报告 > 医药保健

2006-2007 Annual Report on the Development of China's Bio-Pharmaceutical Industry

完成日期:2007年2月
   报告购买热线:010-85860278           放入收藏夹
Report Type Price($) rebate($)  
Paper Report
2200
Words
15000
PDF Email
2400
pages
0
PDF CD
Charts
0
All price
Some Sections
Report's Content
Framework of the Report
Main Conclusions
Key Findings
I. Overview of the Global Bio-Pharmaceutical Industry in 2006
  (I) Market Size and Characteristics
    1. Market Size and Growth in 2006
    2. Market Characteristics in 2006
    3. Application of New Technologies
  (II) Major Countries & Regions
    1. U.S.A
    2. Europe
    3. Denmark
    4. Singapore
II. Overview of China's Bio-Pharmaceutical Industry, 2005-2006
  (I) Development Environment
    1. Policy Environment
    2. Investment Environment
    3. Market Environment
    4. Information Service Environment
  (II) Present Situation
    1. Industry Size
    2. Molecular Biological Materials
    3. Pharmaceutical Materials
    4. Biological Equipment and Methods
    5. Biological Evolution and Ecological Materials
    6. Plant Materials
    7. Animal Materials
  (III) Characteristics
    1. New technology becomes main conventional methods in the development of bio-pharmaceuticals
    2. Bio-pharmaceutical enterprises engaged in closer cooperation, with finer division of work
    3. The high-end R&D of new products dramatically boosts the industry's competitiveness
    4. Outsourcing becomes bio-pharmaceutical enterprises' important development strategy
  (IV) Existing Problems
    1. Low Industrialization Degree, Long Product Cycle
    2. Low Innovation Degree, Lack of Key Technology
    3. Loose Market Regulation, Decreased Product Credit
  (V) Industry Segments
    1. Genetic Engineering Drugs
    2. Antibody Engineering Pharmaceutics
    3. Blood Products
    4. Vaccines
    5. Diagnosis Reagents
    6. Biochips
    7. Chemical Medicine
    8. Traditional Chinese Medicine
III. Analysis of the Industry Chain of China's Bio-Pharmaceutical Industry in 2006
  (I) Structure of Industry Chain
    1. Technology Platform
    2. Research & Development
    3. Clinical Drugs
    4. Translating Research Results into Products
    5. Channels
  (II) Present Situation of Supply & Demand in the Industry Chain
  (III) Characteristics of the Industry Chain & Problems
    1. Basic technology platforms are completed but underutilized
    2. Cross-regional transfer of product technology is brisk but somewhat blind
    3. Despite strong R&D capability, the loss of R&D results is alarming
IV. Analysis of the Competitiveness of China's Bio-Pharmaceutical Industry in 2006
  (I) Competition Model
    1. Product Price
    2. Brand Competition
    3. Channel Competition
    4. Technical Competition
  (II) Competition Situation
    1. Overall Competition Situation
    2. Potential Entrants and Substitute Products
    3. Distribution of Leading Brands
  (III) Leading Brands' Strategies
    1. Tiantan Biological
    2. Novo Nordisk
    3. ...
V. Development Trend of China's Bio-Pharmaceutical Industry, 2007-2009
  (I) Impetuses
    1. Policy Factors
    2. Economic Factors
    3. Social Factors
    4. Technical Factors
  (II) Development Trend
    1. Trend of Production and Consumption
    2. Development Trend of Products
    3. Trend of Technological Innovation
    4. Trend of Competition
VI. Forecast of China's Bio-Pharmaceutical Industry, 2007-2009
  (I) Analysis of Development Potential
  (II) Forecast of Development
    1. Forecast of Size
    2. Forecast of Structure
VII. Investment Opportunities in China's Bio-Pharmaceutical Industry, 2007-2009

  (I) Index System
  (II) Investment Opportunities
VIII. Recommendations from Our.
  (I) Strategic Recommendations
  (II) Investment Recommendations


List of Tables
  Size of China's Bio-Pharmaceutical Market, 2005-2006
  Size of China's Genetic Engineering Drugs Market in 2006
  Size of China's Antibody Engineering Pharmaceutics Market in 2006
  Size of China's Blood Products Market in 2006
  Size of China's Vaccine Market in 2006
  Size of China's Biochip Market in 2006
  
  ...

List of Figures
  Size of the Global Bio-Pharmaceutical Market, 2006-2007
  Development of the U.S.A Bio-Pharmaceutical Market, 2006-2007
  Development of the European Bio-Pharmaceutical Market, 2006-2007
  Development of the Danish Bio-Pharmaceutical Market, 2006-2007
  Development of Singapore's Bio-Pharmaceutical Market, 2006-2007
  ...
  
Report's synopsis
  In 2006, China's bio-pharmaceutical industry grew steadily by some 15%. Biopharmaceutical enterprises' revenue rose sharply but the growth of profits evidently slowed down. Competition shifted to new technologies and new fields. As large enterprises pressed ahead with their internationalization process, the R&D outsourcing market where SMEs play a leading role experienced remarkable growth.
  The growth of therapeutic drugs outstrips that of diagnosis drugs. Interferon, EPO, CSF, recombinant human insulin, and genetic engineering vaccine for Hepatitis B are still playing a leading role in the market. With the promulgation of relevant policies, in 2006 and 2007, target identification, animal and plant breed and drug molecular design, genetic manipulation, protein engineering, human tissue engineering based on stem cells and new-generation industrial biotechnology will see rapid development and are likely to become mainstream in the market.
  In the face of competition and changes and challenges in the market, Our releases the 2006-2007 Annual Report on the Development of China's Bio-Pharmaceutical Industry, which helps vendors, investors, and industry chain grasp the pulse of China's bio-pharmaceutical industry in the following aspects, and comb the development course of segment application value -
  Backed by accurate market description data, the report depicts the development of the industry in 2006 from various angles, e.g. industry structure, research and development, production and manufacturing, raw materials, regional distribution, distribution channels, and price factors, to discern the industry's development trend.
  In briefly analyzing major brands' competition performance in 2006, it sums up enterprises' successes and failures in the dimension of shares of market segments, competition situation, and competition strategy, and reviews the makings of leading players.
  After presenting in-depth quantitative forecast of the market, it conducts modeling regression and expert verification for the whole market and market segments, and obtains valuable trend analysis and quantitative results.
  Moreover, it examines impetuses and obstacles to market segments, and conducts multidimensional analysis of user demand.
  
Related links
                            【Back】     【Close
报告购买流程
1.选择报告

 按行业浏览
 按名称查询
2.定购报告

         13716899065
传真:010-85863454
服务邮箱:

联系人:段小姐
3.付款方式

*银行电汇

开户名:北京蓝宏智业网络信息技术有限公司
帐号:
0200003809067055806

开户行:中国工商银行八里庄支行
*邮局汇款

地址:北京市朝阳区八里庄西里99号住邦2000商务中心2号楼11层
邮 编:100025
*上门收取

 (北京四环以内)
4.发货时间

3-5天(定制报告除外)
5.送货方式


电子版报告:

 Email或光盘发送
纸介版报告:

 北京—快递、上门
 外地—邮政EMS
 国外—敦豪快递
广告服务 - 法律条款 - 注册指南 - 关于我们 - 企业客户
Copyright © 1999-2008 3see.com All Rights Reserved
北京信通四方企业顾问有限公司 版权所有 京ICP证080069号
TEL:86-10-85863259  客服:service@3see.com 
投稿:contribute@3see.com